JASPER + PROMPT Interventions for Autism
(BLOOM Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to understand how combining two therapies, JASPER (a play-based intervention) and PROMPT (a speech-based intervention), can help children with autism improve their speech and language skills. Researchers will compare these combined treatments to JASPER alone to determine which approach better supports children in forming word combinations by Kindergarten. Children who may benefit from this trial are those with autism who use fewer than 20 functional words and have had some early intervention or preschool experience. As an unphased trial, this study offers a unique opportunity for children to potentially enhance their communication skills through innovative therapy combinations.
Will I have to stop taking my current medications?
The trial requires that participants have stable medication over the past 6 months, which suggests you should not change your current medications.
What prior data suggests that these interventions are safe for children with autism?
Research has shown that the JASPER intervention is generally safe for children with autism. Studies have found that children participating in JASPER sessions experienced significant improvements in communication and play skills without major side effects. As a play-based therapy, JASPER offers a gentle and well-tolerated approach for young children.
Specific safety information about combining JASPER with PROMPT is limited. However, PROMPT, a widely used speech therapy method, is usually considered safe. Both JASPER and PROMPT aim to enhance communication and social skills, which are crucial for children with autism.
Although the combined use of these therapies hasn't been widely studied, their individual application in similar contexts hasn't raised major safety concerns. This suggests that using them together is likely well-tolerated. Parents should consult healthcare providers about any concerns before enrolling their children in clinical trials.12345Why are researchers excited about this trial?
Researchers are excited about the JASPER + PROMPT interventions for autism because they offer a unique approach by combining play-based therapy with speech therapy techniques. JASPER is distinctive because it focuses on enhancing social communication skills through structured play, which is different from many traditional methods that mainly emphasize behavioral changes. The addition of PROMPT, a tactile-kinesthetic approach that targets oral-motor skills, provides a comprehensive strategy for improving speech and communication. This combination addresses both social and verbal aspects, potentially offering a more holistic improvement for children with autism compared to standard therapies.
What evidence suggests that the JASPER and PROMPT interventions could be effective for improving speech and language outcomes in children with autism?
Research shows that the JASPER program, which participants in this trial may receive, can greatly improve social communication skills in children with autism. Studies have found that JASPER helps children focus on shared activities, play with imagination, and stay engaged during playtime, all of which are important for learning language.
In this trial, one group will receive JASPER combined with the PROMPT method, which improves speech through guided mouth and tongue movements. Although few studies have examined the combination of JASPER and PROMPT, the success of each method individually suggests they could work well together. Overall, these programs aim to help children progress from using single words to forming phrases, enhancing their communication skills over time.12678Are You a Good Fit for This Trial?
The BLOOM trial is for children aged 48-66 months with Autism Spectrum Disorder who are minimally verbal, using less than 20 functional words. They must have walked by 24 months, have a nonverbal mental age over 12 months, and been in early intervention or preschool for at least three months. Children with severe disabilities like deafness, blindness, cerebral palsy or certain genetic disorders associated with ASD are not eligible.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive JASPER alone or JASPER plus PROMPT interventions, 60-minute sessions twice a week
Exit Assessment
Exit assessments including ELSA Language Sample, PLS-5, ESCS, BOSCC, and EEG
Follow-up
Participants are monitored for language outcomes at 3 months post-exit and when the child turns 6 years of age
What Are the Treatments Tested in This Trial?
Interventions
- JASPER
- PROMPT
JASPER is already approved in United States for the following indications:
- Autism Spectrum Disorder (ASD), specifically for improving social communication and play skills in minimally verbal children
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Los Angeles
Lead Sponsor
National Institutes of Health (NIH)
Collaborator